Adcock Richard has filed 31 insider transactions across 1 company since December 2022.
Most recent transaction: a tax payment of 77560 shares of ImmunityBio, Inc. ($IBRX) on February 22, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 77560 | $8.70 | 560,344.0000 | 984,965,179 | 12.16% | 0.01% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 152439 | $0.00 | 152,439.0000 | 984,965,179 | 50.00% | 0.02% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 152439 | $0.00 | 637,904.0000 | 984,965,179 | 31.40% | 0.02% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 274122 | $0.00 | 625,513.0000 | 984,965,179 | 78.01% | 0.03% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 274122 | $0.00 | 548,246.0000 | 984,965,179 | 33.33% | 0.03% |
| Feb. 10, 2026 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 140048 | $6.93 | 485,465.0000 | 984,965,179 | 22.39% | 0.01% |
| Dec. 31, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 34483 | $0.00 | 51,731.0000 | 984,965,179 | 40.00% | 0.00% |
| Dec. 31, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 34483 | $0.00 | 368,901.0000 | 984,965,179 | 10.31% | 0.00% |
| Dec. 31, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 17510 | $1.98 | 351,391.0000 | 984,965,179 | 4.75% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 152439 | $0.00 | 412,585.0000 | 852,904,340 | 58.60% | 0.02% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 78167 | $3.42 | 334,418.0000 | 852,904,340 | 18.95% | 0.01% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 152439 | $0.00 | 304,878.0000 | 852,904,340 | 33.33% | 0.02% |
| Feb. 10, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | A | Stock Option (right to buy) | 2812500 | $0.00 | 2,812,500.0000 | 852,904,340 | 9999.99% | 0.33% |
| Feb. 10, 2025 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | A | Restricted Stock Units | 822368 | $0.00 | 822,368.0000 | 852,904,340 | 9999.99% | 0.10% |
| Dec. 31, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 34483 | $0.00 | 277,621.0000 | 696,831,296 | 14.18% | 0.00% |
| Dec. 31, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 17475 | $2.56 | 260,146.0000 | 696,831,296 | 6.29% | 0.00% |
| Dec. 31, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 34483 | $0.00 | 86,214.0000 | 696,831,296 | 28.57% | 0.00% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | A | Stock Option (right to buy) | 1591463 | $0.00 | 1,591,463.0000 | 670,867,344 | 9999.99% | 0.24% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | A | Restricted Stock Units | 457317 | $0.00 | 457,317.0000 | 670,867,344 | 9999.99% | 0.07% |
| Feb. 5, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 83334 | $0.00 | 0.0000 | 670,867,344 | 100.00% | 0.01% |
| Feb. 5, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 43165 | $4.04 | 243,138.0000 | 670,867,344 | 15.08% | 0.01% |
| Feb. 5, 2024 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 83334 | $0.00 | 286,303.0000 | 670,867,344 | 41.06% | 0.01% |
| Dec. 31, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 34483 | $0.00 | 220,065.0000 | 421,569,115 | 18.58% | 0.01% |
| Dec. 31, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 17096 | $5.02 | 202,969.0000 | 421,569,115 | 7.77% | 0.00% |
| Dec. 31, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 34483 | $0.00 | 120,697.0000 | 421,569,115 | 22.22% | 0.01% |
| Feb. 5, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 42192 | $4.33 | 185,582.0000 | 421,569,115 | 18.52% | 0.01% |
| Feb. 5, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 83333 | $0.00 | 83,334.0000 | 421,569,115 | 50.00% | 0.02% |
| Feb. 5, 2023 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 83333 | $0.00 | 227,774.0000 | 421,569,115 | 57.69% | 0.02% |
| Dec. 31, 2022 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Common Stock | 8620 | $0.00 | 148,714.0000 | 397,830,044 | 6.15% | 0.00% |
| Dec. 31, 2022 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | F | Common Stock | 4273 | $5.07 | 144,441.0000 | 397,830,044 | 2.87% | 0.00% |
| Dec. 31, 2022 | ImmunityBio, Inc. | $IBRX | Adcock Richard | CEO & President | M | Restricted Stock Units | 8620 | $0.00 | 155,180.0000 | 397,830,044 | 5.26% | 0.00% |